Home/Filings/4/0001408617-09-000014
4//SEC Filing

NPS PHARMACEUTICALS INC 4

Accession 0001408617-09-000014

CIK 0000890465operating

Filed

Jan 21, 7:00 PM ET

Accepted

Jan 22, 5:30 PM ET

Size

8.4 KB

Accession

0001408617-09-000014

Insider Transaction Report

Form 4
Period: 2009-01-20
Rackear Andrew D.
SVP, General Counsel & Sec.
Transactions
  • Award

    Stock Option

    2009-01-20+73,12573,125 total
    Exercise: $5.71Exp: 2019-01-20Common Stock (73,125 underlying)
  • Award

    Stock Option

    2009-01-20+45,00045,000 total
    Exercise: $5.71Exp: 2019-01-20Common Stock (45,000 underlying)
Footnotes (2)
  • [F1]Represents options granted to the Reporting Person under the Issuer's 1998 Stock Option Plan. Options vest and become exercisable 25% on the first anniversary of the date of grant and 6.25% every three months thereafter.
  • [F2]Represents options granted to the Reporting Person under the Issuer's 1998 Stock Option Plan. Options vest and become exercisable 50% on the second anniversary of the date of grant and 50% on the third anniversary of the date of grant, with the actual number of options vesting on such dates determined based on the performance of the Issuer's common stock relative to the performance of stock comprising a selected market index.

Issuer

NPS PHARMACEUTICALS INC

CIK 0000890465

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0000890465

Filing Metadata

Form type
4
Filed
Jan 21, 7:00 PM ET
Accepted
Jan 22, 5:30 PM ET
Size
8.4 KB